JPRN-UMIN000015297招募中2 期
The feasibility study of accelated infliximab infusion from initial administration - The feasibility study of accelated infliximab infusion from initial administration
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)active serious infection 2)active tuberuculosis infection 3)allergy and/or hypersensitivity for mouse-derived protein 4)demyelinating disease(MS) 5)congestive heart failure 6)pregnant, nursing or likelihood of pregnancy woman 7)unable to birth control during and after 6 months from the latest infliximab administration 8)Not suitable for participating in the study for any other reason
研究者
相似试验
已完成
2 期
The feasibility study of accelated infliximab infusion during maintenance phasepatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000007806Chiba University Hospital54
进行中（未招募）
1 期
Feasibility of Accelerated infliximab infusions - Safety and Tolerability in patients wit IBD. FAST - FAST VERSIOThis is a open label, prospective, multicenter trial in patients recieving one hour infusions of infliximab (i.e. Remicade)as part of their daily practice. Main objective: Is to assess the tolerability of Remicade with an infusionsrate of 30 minutes.Patients: eligible patients are those with intestinal fistulas Mb Crohn disease or Ulcerative colitis/IBD. or patietns withEUCTR2008-007519-34-SEniversity of Leuven Hospitals, Division of Gastroenterology50
已完成
不适用
Prospective research of infliximab treatment in active RA patients refractry to anti-interleukin six receptor monoclonal antibody.rheumatoid arthritisJPRN-UMIN000007432Keio University100
已完成
不适用
Prospective Pilot study of Infliximab Dose-intensification determined by Capsule Endoscopic Evaluation of Small Intestinal Involvements in Patients with Crohn's Diseases diseaseCrohn's diseaseJPRN-UMIN000012790Saitama Medical center20
已完成
2 期
A study of infliximab administration method for tacrolimus-resistant active ulcerative colitisulcerative colitisJPRN-UMIN000013716Yokohama City University Medical Center40